IL17A and rheumatoid arthritis: Aberrant activation of Th17 cells and their effector cytokines IL-17A and GM-CSF are implicated in the pathogenesis of various autoimmune and inflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, dermatomyositis, allergy, asthma, and others (2).